| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.170 | 0 | 0 | - | - | - | - | - | - | - |
| Total Income - EUR | 16.838 | 1 | 0 | - | - | - | - | - | - | - |
| Total Expenses - EUR | 2.238 | 84 | 92 | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 14.600 | -83 | -92 | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 14.095 | -83 | -92 | - | - | - | - | - | - | - |
| Employees | 0 | 0 | 0 | - | - | - | - | - | - | - |
Check the financial reports for the company - Biomed International S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Current Assets | 17.391 | 13.086 | 13.128 | - | - | - | - | - | - | - |
| Inventories | 72 | 71 | 70 | - | - | - | - | - | - | - |
| Receivables | 17.268 | 12.983 | 13.026 | - | - | - | - | - | - | - |
| Cash | 50 | 32 | 31 | - | - | - | - | - | - | - |
| Shareholders Funds | 7.214 | 7.057 | 6.846 | - | - | - | - | - | - | - |
| Social Capital | 49 | 49 | 48 | - | - | - | - | - | - | - |
| Debts | 10.177 | 6.029 | 6.282 | - | - | - | - | - | - | - |
| Income in Advance | 0 | 0 | 0 | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4618 - 4618" | |||||||||
| CAEN Financial Year |
4618
|
|||||||||
Comments - Biomed International S.r.l.